Skip to main content

Abstract

Systemic diseases associated with inflammatory and necrotizing lesions of blood vessels, ranging from muscular arteries to glomerular capillaries to dermal venules, produce major diagnostic as well as therapeutic challenges to the clinician. Few medical conditions present as diversely both in regard to renal and extra-renal manifestations. Kussmaul and Maier in 1866 originally described a young patient with Bright’s disease and progressive muscular weakness who at autopsy exhibited nodular swelling of arteries, a condition they termed, periarteritis nodosa (1). It subsequently became evident that classical periarteritis nodosa was relatively rare, but the related name, polyarteritis nodosa, became widely accepted to describe a wide variety of vasculitic diseases. Currently, the synonomous term, systemic necrotizing vasculitis, is generally preferred since it can be more appropriately applied to vasculitic diseases with and without nodular vascular lesions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kussmaul A, Maier K: Uber eine bischer nicht beschreibene eigenthumliche Arterienerkrankung (Periarteritis nodosa), Die mit Morbus Brightii und rapid forschreitender allgemeiner Muskellahmung einhergeht. Dtsch Arch Klin Med 1: 484 – 517, 1866.

    Google Scholar 

  2. Zeek PM: Periarteritis nodosa and other forms of necrotizing angiitis. N Engl J Med 248: 764 – 772, 1953.

    Article  PubMed  CAS  Google Scholar 

  3. Cupps TR, Fauci AS: The vasculitides. W.B. Saunders Co, Philadelphia, 1981.

    Google Scholar 

  4. Fauci AS, Haynes BF, Katz P: The spectrum of vasculitis. Clinical, pathologic, immuilologic and therapeutic considerations. Ann Intern Med 89: 660 – 676, 1978.

    PubMed  CAS  Google Scholar 

  5. Fan PT, Davis JA, Somer T, Kaplan L, Bluestone R: A clinical approach to systemic vasculitis. Semin Arthritis Rheum 9: 248 – 304, 1980.

    Article  PubMed  CAS  Google Scholar 

  6. Alarcon-Sepvia D: The necrotizing vasculitides. A new pathogenetic classification. Med Clin N Am 61: 241 – 260, 1977.

    Google Scholar 

  7. Balow JE. Vasculitic diseases. Clin Exp Dial Apheresis 5: 47 – 63, 1981.

    PubMed  CAS  Google Scholar 

  8. Antonovych TT, Mostofi FH: Atlas of Kidney Biopsies. Armed Forces Institute of Pathology, Washington DC, 1980.

    Google Scholar 

  9. Travers RL, Allison DJ, Brettle RP, Hughes GRV: Polyarteritis nodosa: A clinical and angiographic analysis of 17 cases. Semin Arthritis Rheum 8: 184 – 199, 1979.

    Article  PubMed  CAS  Google Scholar 

  10. Sack M, Cassidy JT, Bole GG: Prognostic factors in polyarteritis. J Rheumatol 2: 411 – 420, 1975.

    PubMed  CAS  Google Scholar 

  11. Leib ES, Restivo C, Paulus HE: Immunosuppressive and corticosteroid therapy of polyarteritis nodosa. Am J Med 67: 941 – 947, 1979.

    Article  PubMed  CAS  Google Scholar 

  12. Cohen RD, Conn DL, Ilstrup DM: Clinical features, prognosis and response to treatment in polyarteritis. Mayo Clin Proc 55: 146 – 155, 1980.

    PubMed  CAS  Google Scholar 

  13. Frohnert PP, Sheps SG: Long-term follow-up study of periarteritis nodosa. Am J Med 43: 8 – 14, 1967.

    Article  PubMed  CAS  Google Scholar 

  14. Pirofsky B, Bardana EJ: Immunosuppressive therapy in rheumatic disease. Med Clin N Am 61: 419 – 437, 1977.

    PubMed  CAS  Google Scholar 

  15. Fauci AS, Katz P, Haynes BF, Wolff SM: Cyclophosphamide therapy of severe systemic necrotizing vasculitis. N Engl J Med 301: 235 – 238, 1979.

    Article  PubMed  CAS  Google Scholar 

  16. Elkon KB, Hughes GRV, Pussell BA: Treatment of vasculitis with cyclophosphamide (letter). N Engl J Med 301: 1122 – 1123, 1979.

    Article  PubMed  CAS  Google Scholar 

  17. Fauci AS, Doppman JL, Wolff SM: Cyclophosphamide- induced remissions in advanced polyarteritis nodosa. Am J Med 64: 890 – 894, 1978.

    Article  PubMed  CAS  Google Scholar 

  18. Lockshin MD: Treatment of vasculitis with cyclophosphamide (letter). N Engl J Med 301: 1123, 1979.

    PubMed  CAS  Google Scholar 

  19. Lockwood CM, Pussell B, Wilson CB, Peters DK: Plasma exchange in nephritis. Adv Nephrol 8: 383 – 418.

    Google Scholar 

  20. Chalopin JM, Rifle G, Turc JM, Cortet P, Severac M: Immunological findings during successful treatment of HBsAg–associated polyarteritis nodosa by plasmapheresis alone. Brit Med J 1:308, 1980,

    Google Scholar 

  21. Lockwood CM, Worlledge S, Nicholas A, Cotton C, Peters DK: Reversal of impaired splenic function in patients with nephritis or vasculitis (or both) by plasma exchange. N Engl J Med 300: 524 – 530, 1979.

    Article  PubMed  CAS  Google Scholar 

  22. Wing EJ, Bruns FJ, Fraley DS, Segel DP, Adler S: Infectious complications with plasmapheresis in rapidly progressive glomerulonephritis. JAMA 244: 2423 – 2426, 1980.

    Article  PubMed  CAS  Google Scholar 

  23. Fauci AS, Wolff SM: Wegener’s granulomatosis: studies in eighteen patients and review of the literature. Medicine 52: 535 – 561, 1973.

    Article  PubMed  CAS  Google Scholar 

  24. Wolff SM, Fauci AS, Horn RG, Dale DC: Wegener’s granulomatosis. Ann Intern Med 81: 513 – 525, 1974.

    PubMed  CAS  Google Scholar 

  25. Balow JE: Wegener’s granulomatosis: response of progressive glomerulonephritis to immunosuppressive therapy. In: Schreiner, Winchester, Mattem, Mendelson (eds) Controversies in Nephrology, vol 1. Georgetown University Press, Washington DC, 1980, pp 243 – 247.

    Google Scholar 

  26. Balow JE, Antonovych T, Fauci AS, Wilson CB: The nephritis of Wegener’s granulomatosis (abstract). Kidney Int 14: 706, 1978.

    Google Scholar 

  27. Appel GB, Gee B, Kashgarian M, Hayslett JP: Wegener’s granulomatosis - clinical-pathological correlations and long-term course. Am J Kidney Dis 1: 27 – 37, 1981.

    PubMed  CAS  Google Scholar 

  28. Walton EW: Giant-cell granuloma of the respiratory tract (Wegener’s granulomatosis). Brit Med J 2: 265 – 270, 1968.

    Article  Google Scholar 

  29. Hollander D, Manning RT: The use of alkylating agents in the treatment of Wegener’s granulomatosis. Ann Intern Med 67: 393 – 398, 1967.

    PubMed  CAS  Google Scholar 

  30. Reza MJ, Domfield L, Goldberg LS, Bluestone P, Pearson CM: Wegener’s granulomatosis. Long-term follow-up of patients treated with cyclophosphamide. Arthritis Rheum 18: 501 - 506, 1975.

    Article  PubMed  CAS  Google Scholar 

  31. Van der Woude FJ, Arisz L, Meijer S, Donker AJM, Hoedemaeker PJ, van Overbeek JJM: Wegener’s granulomatosis. A clinicopathological study in twelve patients. Neth J Med 21: 205 – 220, 1978.

    PubMed  Google Scholar 

  32. Norton WL, Suki W, Strunk S: Combined corticosteroid and azathioprine therapy in two patients with Wegener’s granulomatosis. Arch Intern Med 121: 554 – 560, 1968.

    Article  PubMed  CAS  Google Scholar 

  33. Joyce RA, Chervenick PA: Corticosteroid effect on granulopoiesis in mice after cyclophosphamide. J Clin Invest 60: 277 – 283, 1977.

    Article  PubMed  CAS  Google Scholar 

  34. Fauci AS, Dale DC, Balow JE: Glucocorticosteroid therapy: Mechanisms of action and clinical considerations. Ann Intern Med 84: 304 – 315, 1976.

    PubMed  CAS  Google Scholar 

  35. Aldo MA, Benson MD, Comerford FR, Cohen AS: Treatment of Wegener’s granulomatosis with immunosuppressive agents. Arch Intern Med 126: 298 – 305, 1970.

    Article  PubMed  CAS  Google Scholar 

  36. Kuross S, Davin T, Kjellstrand CM: Wegener’s granulomatosis with severe renal failure: clinical course and resuhs of dialysis and transplantation. Clin Nephrol 16: 172 – 180, 1981.

    PubMed  CAS  Google Scholar 

  37. Fauci AS, Balow JE, Brown R, Chazan J, Steinman T, Sahyoun AI, Monaco AP: Renal transplantation in Wegener’s granulomatosis: Successful alternative in renal failure. Am J Med 60: 437 – 440, 1976.

    Article  PubMed  CAS  Google Scholar 

  38. Van Ypersele de Strihou C, Pirson Y, Vanderbroucke JM, Alexandre GP: Haemodialysis and transplantation in Wegener’s granulomatosis. Brit Med J 2: 93 – 94, 1979.

    Article  PubMed  Google Scholar 

  39. Steinman TI, Jaffe BF, Monaco AP, Wolff SM, Fauci AS: Recurrence of Wegener’s granulomatosis after kidney transplantation. Successful re-induction of remission with cyclophosphamide. Am J Med 68: 458 – 460, 1980.

    Article  PubMed  CAS  Google Scholar 

  40. Cameron JS: The nephritis of Schönlein-Henoch purpura; current problems. In: Kincaid-Smith P, d’Apice AJF, Atkins RC (eds) Progress in glomerulonephritis. John Wiley, New York, 1979, p283.

    Google Scholar 

  41. Crumb CK: Renal involvement in Schönlein-Henoch syndrome. In: Suki WN (ed) The Kidney in Systemic Disease. John Wiley, New York, 1976, p 43.

    Google Scholar 

  42. Levy M, Broyer M, Arsan A, Levy-Bentolila D, Habib R: Anaphylactoid purpura nephritis in childhood: Natural history and immunopathology. Adv Nephrol 6: 183 - 228, 1976.

    CAS  Google Scholar 

  43. Meadow SR, Glasgow EF, White RHR, Moncrieff MW, Cameron JS, Ogg CS: Schönlein-Henoch nephritis. Q J Med 41: 241 – 258, 1972.

    PubMed  CAS  Google Scholar 

  44. Kauffmann RH, Herrmann WA, Meyer CJLM, Daha MR, Van Es LA: Circulating IgA-immune complexes in Henoch-Schönlein purpura. A longitudinal study of their relationships to disease activity and vascular deposition of IgA. Am J Med 69: 859 – 866, 1980.

    Article  PubMed  CAS  Google Scholar 

  45. Counahan R, Winterbom MH, White RHR, Heaton JM, Meadow SR, Bluett NH, Swetschin H, Cameron JS, Chantler C: Prognosis of Henoch-Schönlein nephritis in children. Brit Med J 2: 11 – 14, 1977.

    Article  PubMed  CAS  Google Scholar 

  46. Bar-on H, Rosenmann E: Schoenlein-Henoch syndrome in adults: A clinical and histological study of renal involvement. Israel J Med Sci 8: 1702 – 1715, 1972.

    Google Scholar 

  47. Koskimies O, Mir S, Rapóla J, Vilska J: Henoch-Schönlein nephritis: Long term prognosis of unselected patients. Arch Dis Child 56: 482 – 484, 1981.

    Article  PubMed  CAS  Google Scholar 

  48. Hurley RM, Drummond KN: Anaphylactoid purpura nephritis: Clinicopathological correlations. J Pediatr 81: 904 – 911, 1972.

    Article  PubMed  CAS  Google Scholar 

  49. White RHR, Cameron JS, Trounce JR: Immunosuppressive therapy in steroid-resistant proliferative glomerulonephritis accompanied by the nephrotic syndrome. Brit Med J 2: 853 – 860, 1966.

    Article  PubMed  CAS  Google Scholar 

  50. Michael AF, Vernier RL, Drummond KN, Levitt J, Herd- man R, Fish AJ, Good RA: Immunosuppressive therapy of chronic renal disease. N Engl J Med 276: 817 – 828, 1967.

    Article  PubMed  CAS  Google Scholar 

  51. MRC Working Party: Controlled trial of azathioprine and prednisone in chronic renal disease. Brit Med J 2: 239 – 241, 1971.

    Article  Google Scholar 

  52. Pillastre JP, Morel-Maroger L, Richet G: Schönlein-Henoch purpura in adults. Lancet 1: 1243 – 1244, 1971.

    Article  Google Scholar 

  53. Brown CB, Turner D, Ogg CS, Wilson D, Cameron JS, Chantler C, Gill D: Combined immunosuppression and anti-coagulation in rapidly progressive glomerulonephritis. Lancet 2: 1166 – 1171, 1974.

    Article  PubMed  CAS  Google Scholar 

  54. Cameron JS, Gill D, Turner DR, Chantler C, Ogg CS, Vosnides G, Williams DG: Combined immunosuppression and anti-coagulation in rapidly progressive glomerulonephritis. Lancet 2: 923 – 925, 1975.

    Article  PubMed  CAS  Google Scholar 

  55. McKenzie PE, Taylor AE, Woodroffe AJ, Seymour AE, Chan YL, Clarkson AR: Plasmapheresis in glomerulonephritis. Clin Nephrol 12: 97 – 108, 1979.

    PubMed  CAS  Google Scholar 

  56. Ito K, Narumi F, Ono M, Kawaguchi H: The evaluation of clinical effect of plasma exchange therapy on purpura nephritis in childhood (abstract). Int Congr Nephrol 8: 259, 1981.

    Google Scholar 

  57. Baliah TD, Kim KH, Antigone S, Anthone R, Montes M, Andres GA: Recurrence of Henoch-Schönlein purpura glomerulonephritis in transplanted kidneys. Transplantation 18: 343 – 346, 1974.

    Article  PubMed  CAS  Google Scholar 

  58. Beale MG, Nash GS, Bertovich MJ, MacDermott RP: Similar disturbances in B cell activity and regulatory T cell function in Henoch-Schönlein purpura and systemic lupus erythematosus. J Immunol 128: 486–491, 1982.

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Martinus Nijhoff Publishers, Boston / The Hague / Dordrecht / Lancaster

About this chapter

Cite this chapter

Balow, J.E., Austin, H.A. (1984). Vasculitic Diseases of the Kidney. In: Suki, W.N., Massry, S.G. (eds) Therapy of Renal Diseases and Related Disorders. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-3807-9_20

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-3807-9_20

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-3809-3

  • Online ISBN: 978-1-4613-3807-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics